In addition, MSLN enables cancer cell survival, despite inflammation, due to resisting TNF-α-induced apoptosis, through elevating Akt/PI3K/NF-kB and IL-6/MCL-1 axes (12, 101, 103). The gene discussed is IL6; the disease is cancer.